Possible scenario
Congressional Probe Expands
25% Chance
Congress is likely to treat the grant as evidence that NIH foreign-award controls remain weak despite prior warnings. Hearings and document demands could create headline risk for NIH leadership and academic grant recipients, but the financial-market effect should remain sector-specific and modest.
Secondary impacts
- Healthcare -0.4%
- Business Services -0.2%
Portfolio impact
S&P 500-0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.